Cargando…
Treatment of adynamic bone disease in a haemodialysis patient with teriparatide
Prevalence of adynamic bone disease (ABD), characterized by low bone turnover and absence or a reduced number of osteoblasts and osteoclasts, is increasing steadily over the last years. We present a dialysis patient, with recurrent bone fractures and biopsy-proven ABD, who was treated with teriparat...
Autores principales: | Giamalis, Panagiotis, Economidou, Dominiki, Dimitriadis, Chrysostomos, Memmos, Dimitrios, Papagianni, Aikaterini, Efstratiadis, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370305/ https://www.ncbi.nlm.nih.gov/pubmed/25815175 http://dx.doi.org/10.1093/ckj/sfv005 |
Ejemplares similares
-
Teriparatide Treatment for Hypercalcemia Associated With Adynamic Bone Disease
por: Peugh, Jennifer, et al.
Publicado: (2019) -
Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients
por: Pateinakis, Panagiotis, et al.
Publicado: (2013) -
FGF-23 Levels before and after Renal Transplantation
por: Economidou, Domniki, et al.
Publicado: (2009) -
Associations of serum sclerostin and Dickkopf-related protein-1 proteins with future cardiovascular events and mortality in haemodialysis patients: a prospective cohort study
por: Stavrinou, Eirini, et al.
Publicado: (2020) -
Improving patient safety in haemodialysis
por: Bray, Benjamin D., et al.
Publicado: (2015)